BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7562513)

  • 1. The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist.
    Bolser DC; Blythin DJ; Chapman RW; Egan RW; Hey JA; Rizzo C; Kuo SC; Kreutner W
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1393-8. PubMed ID: 7562513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subtype of the gamma-aminobutyric acid(B) receptor regulates cholinergic twitch response in the guinea pig ileum.
    Marcoli M; Scarrone S; Maura G; Bonanno G; Raiteri M
    J Pharmacol Exp Ther; 2000 Apr; 293(1):42-7. PubMed ID: 10734151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacology of the baclofen homologues 5-amino-4-(4-chlorophenyl)pentanoic acid and the R- and S-enantiomers of 5-amino-3-(4-chlorophenyl)pentanoic acid.
    Karla R; Ebert B; Thorkildsen C; Herdeis C; Johansen TN; Nielsen B; Krogsgaard-Larsen P
    J Med Chem; 1999 Jun; 42(11):2053-9. PubMed ID: 10354414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911.
    Pibiri F; Carboni G; Carai MA; Gessa GL; Castelli MP
    Eur J Pharmacol; 2005 May; 515(1-3):94-8. PubMed ID: 15893746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea pig.
    Bolser DC; DeGennaro FC; O'Reilly S; Chapman RW; Kreutner W; Egan RW; Hey JA
    Br J Pharmacol; 1994 Dec; 113(4):1344-8. PubMed ID: 7889290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GABA(B) receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination.
    Filip M; Frankowska M; Przegaliński E
    Eur J Pharmacol; 2007 Nov; 574(2-3):148-57. PubMed ID: 17698060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Chloro,4-methoxyfendiline is a potent GABA(B) receptor potentiator in rat neocortical slices.
    Ong J; Parker DA; Marino V; Kerr DI; Puspawati NM; Prager RH
    Eur J Pharmacol; 2005 Jan; 507(1-3):35-42. PubMed ID: 15659292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
    Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
    Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GABA(B) antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat.
    Brebner K; Froestl W; Roberts DC
    Psychopharmacology (Berl); 2002 Feb; 160(1):49-55. PubMed ID: 11862373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human brain cholecystokinin: release of cholecystokinin-like immunoreactivity (CCK-LI) from isolated cortical nerve endings and its modulation through GABA(B) receptors.
    Raiteri M; Bonanno G; Paudice P; Cavazzani P; Schmid G
    J Pharmacol Exp Ther; 1996 Aug; 278(2):747-51. PubMed ID: 8768727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A, 5-HT2, and GABAB receptors interact to modulate neurotransmitter release probability in layer 2/3 somatosensory rat cortex as evaluated by the paired pulse protocol.
    Torres-Escalante JL; Barral JA; Ibarra-Villa MD; Pérez-Burgos A; Góngora-Alfaro JL; Pineda JC
    J Neurosci Res; 2004 Oct; 78(2):268-78. PubMed ID: 15378508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activities of the enantiomeric GABA(B) receptor agonists CGP 44532 and 44533 in central and peripheral tissues.
    Ong J; Bexis S; Marino V; Parker DA; Kerr DI; Froestl W
    Eur J Pharmacol; 2001 Jan; 412(1):27-37. PubMed ID: 11166733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig.
    McLeod RL; Aslanian R; del Prado M; Duffy R; Egan RW; Kreutner W; McQuade R; Hey JA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):43-50. PubMed ID: 9765320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the antiabsence effects of SCH 50911, a GABA-B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models.
    Hosford DA; Wang Y; Liu CC; Snead OC
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1399-403. PubMed ID: 7562514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
    Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
    Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.